Sponsor:  American Diabetes Association (ADA)

Sponsor Program Solicitation: Accelerator (ACC)
Funding Amount: $325,000 per year
Duration: 5 years


Status of this Limited Submission Opportunity

Closed


Deadlines

NU Pre-Proposal Deadline: 05/28/2014
Sponsor Deadline: 07/01/2014


Eligibility and Nomination Requirements

Only one nomination per institution for all programs combined is allowed. This opportunity is still open. If you are interested in applying, please contact Karen Drew (x4824) as early as possible.

Awards are available to individuals with established records of independent productivity in research, in two distinct categories:

  • Early Investigator: Early-career diabetes investigators proposing innovative and ambitious diabetes-related research programs. Applicants must hold faculty positions and have demonstrated independent productivity in diabetes research. Applicants may currently hold independent NIH funding (K, U or R awards, including an initial R01/U01) but must not have applied for, or received, an R01/U01 renewal or a second R01/U01 award.
  • New to Diabetes Research: Established investigators with exceptional productivity in fields other than diabetes research who would like to apply their expertise to innovative diabetes-related research topics. Applicants must hold faculty positions and have demonstrated independent productivity. Applicants cannot have previously received national grant support in diabetes research.

Candidates must be identified through institutional nomination; applications will be accepted only from individuals with the appropriate institution support.


Funding Areas

Pathway supports innovative basic, clinical, translational, epidemiological, behavioral, or health services research relevant to any diabetes type, diabetes-related disease state, or diabetes complication. The Association seeks exceptional candidates from a broad range of disciplines, including medicine, biology, chemistry, computing, physics, mathematics and engineering.


Awards are designed to support exceptional early-career researchers who have distinguished themselves as promising investigators and are in the beginning stages of establishing successful, independent diabetes research programs; and talented established investigators in fields other than diabetes who are interested in applying their skills and expertise to diabetes research.